Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Rapport Therapeutics, Inc. | Chief Operations Officer | Common Stock | 158K | Jun 6, 2024 | Direct | ||
Cyclerion Therapeutics, Inc. | Chief Operating Officer | Employee Stock Option (Right to Buy) | 135K | Jan 20, 2022 | Direct | ||
Rapport Therapeutics, Inc. | Chief Operations Officer | Stock Option (Right to Buy) | 88.4K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RAPP | Rapport Therapeutics, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Chief Operations Officer |
RAPP | Rapport Therapeutics, Inc. | Jun 6, 2024 | 0 | $0 | 3 | Jun 6, 2024 | Chief Operations Officer |
CYCN | Cyclerion Therapeutics, Inc. | Jan 20, 2022 | 1 | $0 | 4 | Jan 24, 2022 | Chief Operating Officer |
CYCN | Cyclerion Therapeutics, Inc. | Dec 9, 2021 | 1 | $0 | 4 | Dec 10, 2021 | Chief Operating Officer |